Martin McMahon

Martin McMahon

UNVERIFIED PROFILE

Are you Martin McMahon?   Register this Author

Register author
Martin McMahon

Martin McMahon

Publications by authors named "Martin McMahon"

Are you Martin McMahon?   Register this Author

85Publications

1652Reads

34Profile Views

Linking brain tumors and epileptic seizures.

Nat Med 2018 11;24(11):1638-1639

Huntsman Cancer Institute and Department of Dermatology, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41591-018-0249-6
Publisher Site
http://dx.doi.org/10.1038/s41591-018-0249-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668703PMC
November 2018

Professional collaboration in searching the evidence for an ill-defined concept.

Health Info Libr J 2018 Sep 22;35(3):246-250. Epub 2018 Jun 22.

Department of Health and Social Services, States of Jersey, St Helier, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hir.12222DOI Listing
September 2018

P2A-Fluorophore Tagging of BRAF Tightly Links Expression to Fluorescence In Vivo.

PLoS One 2016 27;11(6):e0157661. Epub 2016 Jun 27.

Helen Diller Family Comprehensive Cancer, University of California San Francisco, San Francisco, CA, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157661PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922626PMC
July 2017

PIK3CA-mutated melanoma cells rely on cooperative signaling through mTORC1/2 for sustained proliferation.

Pigment Cell Melanoma Res 2017 05 20;30(3):353-367. Epub 2017 Apr 20.

Helen Diller Family Comprehensive Cancer Center, Department of Cellular & Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12586DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411292PMC
May 2017

Rational targeting of BRAF and PI3-Kinase signaling for melanoma therapy.

Mol Cell Oncol 2016 May 7;3(3):e1033095. Epub 2015 May 7.

Helen Diller Family Comprehensive Cancer Center and Department of Cell and Molecular Pharmacology, University of California , San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/23723556.2015.1033095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909456PMC
May 2016

PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.

Cancer Res 2015 Dec 13;75(24):5378-91. Epub 2015 Nov 13.

Helen Diller Family Comprehensive Cancer Center and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-1249DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681648PMC
December 2015

AKT1 Activation Promotes Development of Melanoma Metastases.

Cell Rep 2015 Nov 22;13(5):898-905. Epub 2015 Oct 22.

Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.cell.com/cell-reports/pdf/S2211-1247(15)01082-7.p
Web Search
http://www.cell.com/cms/attachment/2040452974/2053964384/mmc
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S221112471501082
Publisher Site
http://dx.doi.org/10.1016/j.celrep.2015.09.057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646731PMC
November 2015

TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis.

Cancer Res 2015 Aug 22;75(15):3167-80. Epub 2015 May 22.

Helen Diller Family Comprehensive Cancer Center and Department of Cell and Molecular Pharmacology, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-3701DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526430PMC
August 2015

Mind your attitude.

Authors:
Martin McMahon

Nurs Stand 2015 Aug;29(51):63

States of Jersey and Channel Islands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7748/ns.29.51.63.s47DOI Listing
August 2015

Intermittent dosing in melanoma.

Authors:
Martin McMahon

Clin Adv Hematol Oncol 2015 Jun;13(6):348-50

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839533PMC
June 2015

Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanoma.

Nat Genet 2015 May 13;47(5):486-95. Epub 2015 Apr 13.

1] Cancer Research Program, Houston Methodist Research Institute, Houston, Texas, USA. [2] Institute of Molecular and Cell Biology, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844184PMC
May 2015

PI3'-kinase inhibition forestalls the onset of MEK1/2 inhibitor resistance in BRAF-mutated melanoma.

Cancer Discov 2015 Feb 3;5(2):143-53. Epub 2014 Dec 3.

Helen Diller Family Comprehensive Cancer Center and Department of Cell and Molecular Pharmacology, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-14-0856DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320669PMC
February 2015

Activating BRAF and PIK3CA mutations cooperate to promote anaplastic thyroid carcinogenesis.

Mol Cancer Res 2014 Jul 25;12(7):979-86. Epub 2014 Apr 25.

Authors' Affiliations: Helen Diller Family Comprehensive Cancer Center; Departments of Cell and Molecular Pharmacology, and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-14-0158-TDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635659PMC
July 2014

Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond.

Nat Rev Cancer 2014 Jul;14(7):455-67

Helen Diller Family Comprehensive Cancer Center and Department of Cell and Molecular Pharmacology, University of California, San Francisco, California 94158, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc3760DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250230PMC
July 2014

Cancer biology: Enzyme meets a surprise target.

Nature 2014 Jun 21;510(7504):225-6. Epub 2014 May 21.

Helen Diller Family Comprehensive Cancer Center and the Department of Cell and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94158, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature13343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250228PMC
June 2014

Isolation and molecular characterization of circulating melanoma cells.

Cell Rep 2014 May 18;7(3):645-53. Epub 2014 Apr 18.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; Howard Hughes Medical Institute, Bethesda, MD 20815, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.cell.com/cell-reports/pdf/S2211-1247(14)00217-4.p
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S221112471400217
Publisher Site
http://dx.doi.org/10.1016/j.celrep.2014.03.039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079008PMC
May 2014

p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer.

Proc Natl Acad Sci U S A 2014 Apr 7;111(16):E1600-9. Epub 2014 Apr 7.

Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1404357111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000830PMC
April 2014

BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation.

Mol Cancer Res 2014 Mar 14;12(3):447-63. Epub 2014 Jan 14.

Diller Cancer Research Building, MC-0128, 1450 Third Street, Room HD-365, University of California, San Francisco, CA 94158.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-13-0224-TDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966216PMC
March 2014

The fastest Western in town: a contemporary twist on the classic Western blot analysis.

J Vis Exp 2014 Feb 5(84):e51149. Epub 2014 Feb 5.

Diller Cancer Research Building, University of California, San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/51149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028330PMC
February 2014

Hematopoietic expression of oncogenic BRAF promotes aberrant growth of monocyte-lineage cells resistant to PLX4720.

Mol Cancer Res 2013 Dec 23;11(12):1530-41. Epub 2013 Oct 23.

Department of Laboratory Medicine, University of California, San Francisco, 513 Parnassus Ave, Room S-561, San Francisco, CA 94143-0100.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-13-0294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869667PMC
December 2013

Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors.

Cancer Discov 2013 Nov 21;3(11):1272-85. Epub 2013 Aug 21.

1Cancer Institute of New Jersey, New Brunswick; 2Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey; and 3Department of Cellular & Molecular Pharmacology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823822PMC
November 2013

Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progression.

Cancer Res 2013 Nov 9;73(21):6448-61. Epub 2013 Sep 9.

Authors' Affiliations: Helen Diller Family Comprehensive Cancer Center; Departments of Cell and Molecular Pharmacology, Hematology and Oncology, and Pathology, University of California, San Francisco, San Francisco, California; and Surgical Oncology Research Laboratory, Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-0681DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825323PMC
November 2013

Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma.

Proc Natl Acad Sci U S A 2013 Nov 21;110(45):18226-31. Epub 2013 Oct 21.

Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1317577110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831456PMC
November 2013

Elucidating distinct roles for NF1 in melanomagenesis.

Cancer Discov 2013 Mar 21;3(3):338-49. Epub 2012 Nov 21.

Genetics Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-12-0313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595355PMC
March 2013

Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma.

J Pathol 2013 Jan 20;229(1):132-40. Epub 2012 Nov 20.

Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552559PMC
January 2013

Analysis of mRNA profiles after MEK1/2 inhibition in human pancreatic cancer cell lines reveals pathways involved in drug sensitivity.

Mol Cancer Res 2012 Dec 25;10(12):1607-19. Epub 2012 Jul 25.

Helen Diller Family Comprehensive Cancer Center & Department of Cell and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-12-0188DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261949PMC
December 2012

Regulated temporal-spatial astrocyte precursor cell proliferation involves BRAF signalling in mammalian spinal cord.

Development 2012 Jul 6;139(14):2477-87. Epub 2012 Jun 6.

Department of Pediatrics, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research and Howard Hughes Medical Institute, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/dev.077214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383225PMC
July 2012

MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E.

Cancer Res 2012 Jun 17;72(12):3048-59. Epub 2012 Apr 17.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco 94158, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-3649DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393094PMC
June 2012

E-cadherin regulates the behavior and fate of epithelial stem cells and their progeny in the mouse incisor.

Dev Biol 2012 Jun 18;366(2):357-66. Epub 2012 Apr 18.

Department of Orofacial Sciences and Program in Craniofacial and Mesenchymal Biology, UCSF, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ydbio.2012.03.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690274PMC
June 2012

Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouse.

Cancer Res 2011 Jun 21;71(11):3863-71. Epub 2011 Apr 21.

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-4463DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107361PMC
June 2011

Parsing out the complexity of RAF inhibitor resistance.

Authors:
Martin McMahon

Pigment Cell Melanoma Res 2011 Apr 12;24(2):361-5. Epub 2011 Jan 12.

Helen Diller Family Comprehensive Cancer Center & Department of Cell and Molecular Pharmacology, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1755-148X.2010.00824.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075071PMC
April 2011

Characterization of melanoma cells capable of propagating tumors from a single cell.

Cancer Res 2010 Jan;70(1):388-97

Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-2153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026296PMC
January 2010

Down-regulation of Cdx2 in colorectal carcinoma cells by the Raf-MEK-ERK 1/2 pathway.

Cell Signal 2009 Dec 14;21(12):1846-56. Epub 2009 Aug 14.

Laboratory of Developmental Genetics & Imprinting, The Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellsig.2009.07.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625762PMC
December 2009

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.

Nat Genet 2009 May 12;41(5):544-52. Epub 2009 Mar 12.

Cancer Research Institute & Department of Cell and Molecular Pharmacology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705918PMC
May 2009

Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.

Pigment Cell Melanoma Res 2008 Oct 28;21(5):534-44. Epub 2007 Jul 28.

Cancer Research Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1755-148X.2008.00491.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916913PMC
October 2008

A model of intussusceptive angiogenesis.

Novartis Found Symp 2007 ;283:37-42; discussion 42-5, 238-41

Department of *Anatomy, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
March 2008

Meeting report: fourth international congress of the Society for Melanoma Research.

Pigment Cell Melanoma Res 2008 Feb;21(1):15-26

Department of Pediatric Hematology/Oncology and Melanoma Program, Dana-Farber Cancer Institute and Children's Hospital of Boston, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1755-148X.2007.00437.xDOI Listing
February 2008

A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors.

Genes Dev 2007 Feb 13;21(4):379-84. Epub 2007 Feb 13.

Cancer Research Institute, Department of Cellular and Molecular Pharmacology, University of California, San Francisco Comprehensive Cancer Center, California 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/gad.1516407DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804325PMC
February 2007

Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells.

Proc Natl Acad Sci U S A 2006 Feb 16;103(9):3274-9. Epub 2006 Feb 16.

The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0511113103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413910PMC
February 2006

The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what's genetics got to do with it?

Expert Opin Ther Targets 2005 Oct;9(5):1009-30

Brody School of Medicine at East Carolina University, Department of Microbiology & Immunology, Greenville, NC 27858, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728222.9.5.1009 DOI Listing
October 2005

Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines.

Genes Chromosomes Cancer 2005 Sep;44(1):37-51

Cancer Research Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco Comprehensive Cancer Center, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20216DOI Listing
September 2005

Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokines.

Cell Cycle 2005 Jun 7;4(6):822-30. Epub 2005 Jun 7.

Department of Microbiology & Immunology, Brody School of Medicine, East Carolina University, Greenville, North Carolina 27858, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.4.6.1724DOI Listing
June 2005

Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.

Cancer Res 2005 Jun;65(11):4870-80

Cancer Research Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco Comprehensive Cancer Center, San Francisco, California 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-2848DOI Listing
June 2005

Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor.

Mol Cell Biol 2005 Jan;25(1):220-32

Department of Pathology, Wake Forest University Health Sciences, 2102 Gray Building, Medical Center Blvd., Winston-Salem, NC 27157, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/MCB.25.1.220-232.2005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC538777PMC
January 2005

Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT.

Mol Cell Biol 2004 Dec;24(24):10868-81

Cancer Research Institute and Department of Cellular and Molecular Pharmacology, UCSF Comprehensive Cancer Center, 2420 Sutter St., Box 0128, San Francisco, CA 94143-0128, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/MCB.24.24.10868-10881.2004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC533961PMC
December 2004

Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.

Oncogene 2004 Oct;23(47):7810-20

Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208055DOI Listing
October 2004

Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion.

J Biol Chem 2004 Jul 5;279(28):28880-8. Epub 2004 May 5.

Department of Pediatrics, The Whittier Institute, and Moores Comprehensive Cancer Center, University of California at San Diego, La Jolla, California 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M404075200DOI Listing
July 2004

Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf.

J Clin Invest 2004 Feb;113(4):539-50

Gladstone Institute of Cardiovascular Disease, San Francisco, California 94141-9100, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI18829DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC338259PMC
February 2004

Ras-induced serine phosphorylation of the focal adhesion protein paxillin is mediated by the Raf-->MEK-->ERK pathway.

Exp Cell Res 2003 Jul;287(2):325-38

Cancer Research Institute and Department of Cellular and Molecular Pharmacology, UCSF/Mt. Zion Comprehensive Cancer Center, 2340 Sutter St., San Francisco, CA 94143-0128, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0014-4827(03)00122-8DOI Listing
July 2003

Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.

Cancer Res 2003 May;63(9):2088-95

Cancer Research Institute, University of California, San Francisco 94143, USA.

View Article

Download full-text PDF

Source
May 2003

De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.

J Virol 2002 Mar;76(5):2440-8

Department of Microbiology and Medicine, Howard Hughes Medical Institute, University of California-San Francisco, 513 Parnassus Ave., San Francisco, CA 94143-0414, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC153827PMC
http://dx.doi.org/10.1128/jvi.76.5.2440-2448.2002DOI Listing
March 2002

Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells.

Exp Cell Res 2002 Feb;273(1):21-33

Department of Neurological Surgery, Cancer Research Institute, San Francisco, California 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/excr.2001.5424DOI Listing
February 2002